Abbott Laboratories (ABT)
NYSEHealth CareMedical DevicesSnapshot 2026-07-08
$95.09-0.78%
Close 2026-07-08 · 1-day change
Reading ABT? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ABT free→NYSEHealth CareMedical DevicesSnapshot 2026-07-08
Reading ABT? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track ABT free→QuarterlyIQ Insights · ABT
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Met or beat guidance 100% of the last 8 guided quarters · 22.6% avg surprise
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated strong grew net income 50% of the time over the next year (vs 42% for the rest of the cohort, n=9129).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the trailing year it converted 1.51x of net income into operating cash flow. Historically, Health Care names rated neutral grew net income 49% of the time over the next year (vs 41% for the rest of the cohort, n=3127).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
10 material management or governance events in the past 24 months, led by executive changes. Historically, Health Care names rated neutral grew net income 50% of the time over the next year (vs 48% for the rest of the cohort, n=4965).
Not investment advice. As of 2026-07-08.